Interestingly, the tyrosine kinase KIT was reported to be overexpressed in basal breast cancers [35] and BRCA1-associated basal cancers [7], suggesting that it may serve as a useful prognostic marker or therapeutic target. The gene discussed is KIT; the disease is breast cancer.